AVELUMAB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED AVELUMAB

  • Yentel, Diane D. (PI)
  • Hughes, Brett B. (PI)
  • Sweeney, Ellen (CoPI)
  • Hyman, Ilene (CoPI)
  • Schnurr, Matthew A. (CoPI)
  • Thomas, Ren (CoPI)
  • Rutland, Ted W. (CoPI)
  • Haluza-delay, Randolph B. (CoPI)
  • Teelucksingh, Cheryl (CoPI)

Project: Research project

Project Details

Description

The purpose of this Master Protocol for Avelumab Continuation Sub-Studies is to provide continued treatment access, safety follow-up, and when applicable, overall survival follow-up for eligible participants who continue to derive a benefit from study intervention in the Pfizer-sponsored avelumab parent studies. Additional follow-up safety data collection will permit further characterization of the safety profile of the investigational drug(s) in participants continuing to receive study intervention.

StatusActive
Effective start/end date1/1/16 → 11/30/26

Funding

  • Social Sciences and Humanities Research Council of Canada: US$18,878.00

ASJC Scopus Subject Areas

  • Social Sciences(all)
  • Safety Research
  • Medicine(all)
  • Global and Planetary Change
  • Management, Monitoring, Policy and Law
  • Renewable Energy, Sustainability and the Environment

Access Project